Effects of magnesium on postprandial serum lipid responses in healthy human subjects

British Journal of Nutrition

Volumn 103, Issue 4, 2010, Pages 469-472

  Kishimoto, Yoshimi ^a   Tani, Mariko ^a   Uto Kondo, Harumi ^b   Saita, Emi ^a   Iizuka, Maki ^a   Sone, Hirohito ^a   Yokota, Kuninobu ^c   Kondo, Kazuo ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Magnesium; Postprandial hyperlipidaemia; Remnant lipoprotein; TAG

Indexed keywords

APOLIPOPROTEIN B48; CHOLESTEROL; CHYLOMICRON; MAGNESIUM CHLORIDE; REMANT LIKE PARTICLE CHOLESTEROL; UNCLASSIFIED DRUG; ANTILIPEMIC AGENT; LIPID; LIPOPROTEIN; MAGNESIUM; REMNANT LIKE PARTICLE CHOLESTEROL; REMNANT-LIKE PARTICLE CHOLESTEROL; TRACE ELEMENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; LIPID ABSORPTION; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; BUTTER; DIET; FAT INTAKE; METABOLISM; REFERENCE VALUE;

ANIMALIA;

ADULT; ANTILIPEMIC AGENTS; APOLIPOPROTEIN B-48; ATHEROSCLEROSIS; BUTTER; CHOLESTEROL; CHYLOMICRONS; CROSS-OVER STUDIES; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; HUMANS; LIPIDS; LIPOPROTEINS; MAGNESIUM; MAGNESIUM CHLORIDE; MALE; MICRONUTRIENTS; POSTPRANDIAL PERIOD; REFERENCE VALUES; TRIGLYCERIDES;

EID: 77649195349     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992716     Document Type: Article

References (25)

1. Mero N Syvanne M Taskinen MR (1998) Postprandial lipid metabolism in diabetes. Atherosclerosis 141, Suppl. 1, S53-S55.
2. Karpe F (1999) Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 246, 341-355.
3. Krauss RM (1998) Atherogenicity of triglyceride-rich lipo-proteins. Am J Cardiol 81, 13B-17B.
4. Eckel RH, Grundy SM & Zimmet PZ (2005) The metabolic syndrome. Lancet 365, 1415-1428.
5. Shepherd J, Betteridge J & Van Gaal L (2005) Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Curr Med Res Opin 21, 665-682.
6. Al-Delaimy WK, Rimm EB, Willett WC, et al. (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23, 63-70.
7. Abbott RD, Ando F, Masaki KH, et al. (2003) Dietary magnesium intake and the future risk of coronary heart disease (The Honolulu Heart Program). Am J Cardiol 92, 665-669.
8. Peterson DR, Thompson DJ & Nam JM (1970) Water hardness, arteriosclerotic heart disease and sudden death. Am J Epidemiol 92, 90-93.
9. Colditz GA, Manson JE, Stampfer MJ, et al. (1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018-1023.
10. Song Y, Manson JE, Buring JE, et al. (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27, 59-65.
11. Ascherio A, Hennekens C, Willett WC, et al. (1996) Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065-1072.
12. Ascherio A, Rimm EB, Giovannucci EL, et al. (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475-1484.
13. Yokota K, Kato M, Lister F, et al. (2004) Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 23, 506S-509S.
14. Unno T, Tago M, Suzuki Y, et al. (2005) Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 93, 543-547.
15. Bhattacharyya AK, Thera C, Anderson JT, et al. (1969) Dietary calcium and fat. Effect on serum lipids and fecal excretion of cholesterol and its degradation products in man. Am J Clin Nutr 22, 1161-1174.
16. Gacs G & Barltrop D (1977) Significance of Ca-soap formation for calcium absorption in the rat. Gut 18, 64-68.
17. Renaud S, Ciavatti M, Thevenon C, et al. (1983) Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat. Atherosclerosis 47, 187-198.
18. Yacowitz H, Fleischman AI & Bierenbaum ML (1965) Effects of oral calcium upon serum lipids in man. Br Med J 1, 1352-1354.
19. Denke MA, Fox MM & Schulte MC (1993) Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123, 1047-1053.
20. Rayssiguier Y & Gueux E (1986) Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 5, 507-519.
21. Proctor SD & Mamo JC (1996) Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 7, 239-245.
22. Proctor SD & Mamo JC (1998) Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from postprandial lipoproteins. Eur J Clin Invest 28, 497-503.
23. Bradley WA & Gianturco SH (1994) Triglyceride-rich lipo-proteins and atherosclerosis: pathophysiological considerations. J Intern Med Suppl 736, 33-39.
24. Altura BT, Brust M, Bloom S, et al. (1990) Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA 87, 1840-1844.
25. Ravn HB, Korsholm TL & Falk E (2001) Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21, 858-862.